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Abstract 
Annexin A2 (AnxA2) is a phospholipid binding protein that has been implicated in many 
membrane-related cellular functions. AnxA2 is able to bind different acidic phospholipids 
such as phosphatidylserine (PS) and phosphatidylinositol-4,5-bisphosphate (PI2P). This 
binding is mediated by Ca2+-dependent and Ca2+-independent mechanisms. The specific 
functions of annexin A2 related to these two phospholipids and the molecular mechanisms 
involved in their interaction remain obscure. Herein we studied the influence of lipid 
composition on the Ca2+-dependency of AnxA2-mediated membrane bridging and on 
membrane fluidity. Membrane models of ten different lipid compositions and detergent-
resistant membranes from two cellular sources were investigated. The results show that the 
AnxA2-mediated membrane bridging requires 3 to 50 times less calcium for PS-membranes 
than for PI2P-membranes. Membrane fluidity was measured by the ratiometric fluorescence 
parameter generalized polarization method with two fluorescent probes. Compared to controls 
containing low phospholipid ligand, AnxA2 was found to reduce the membrane fluidity of 
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PI2P-membranes twice as much as the PS-membranes in the presence of calcium. On the 
contrary, at mild acidic pH in the absence of calcium AnxA2 reduces the fluidity of the PS-
membranes more than the PI2P-membranes. The presence of cholesterol on the bilayer 
reduced the AnxA2 capacity to reduce membrane fluidity. The presented data shed light on 
the specific roles of PI2P, PS and cholesterol present on membranes related to the action of 
Annexin A2 as a membrane bridging molecule during exocytosis and endocytosis events and 
as a plasma membrane domain phospholipid packing regulator. 
 
Keywords: Anionic phospholipids; Annexin A2; Calcium; Cholesterol; Membrane domains; 
Membrane fluidity. 
 
1. Introduction 
The characterization of lipid diversity and the distribution of specific lipids in cell organelles 
and plasma membrane domains is becoming essential for the fine understanding of membrane 
cell biology (for a review see [1]). Annexins (Anxs) (footnote ) are a family of calcium and 
phospholipid binding proteins involved in different membrane-related cellular functions [2, 
3]. Anxs are found in different organelles and specific regions of the plasma membrane and 
show different affinities for cellular membranes with specific calcium requirements [4, 5]. 
Their Ca2+-sensitivity for binding to different phospholipids has been studied in vitro 
revealing that each Anx possesses specific preferences for different phospholipids. For 
example, AnxA5 Ca2+-sensitivity was reported to be in the range of 0.16 to 0.75 mM for the 
following phospholipids in the order dioleoylphosphatidylglicerol < 
dioleoylphosphatidylserine < phosphatidylinositol (PI) < phosphatidic acid (PA) [6]. For 
AnxA4, the Ca2+-sensitivity was in the range of 40 to 120 μM for PA < phosphatidylserine 
(PS) < phosphatidylglicerol (PG) < phosphatidylinositol-4,5-bisphosphate (PI2P) < PI in this 
order [7]. Moreover, the individual calcium binding sites of the four annexin repeats can show 
characteristic affinities for the different phospholipids. For example, the fourth repeat of 
AnxA4 was reported to be involved in PS and PI binding but not in PG binding [8].  
Phospholipid organization and distribution can be modified by protein binding. Phospholipid 
clustering by Anxs has been reported in vitro and in vivo. AnxA2 is able to induce PS and 
PI2P segregation and clustering in vitro [9, 10]. Anxs A4 and A6 were also shown to induce 
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clustering of their binding phospholipids PG and PA respectively [11, 12]. Moreover, the 
speed of PA clustering depended on the presence of phosphatidylcholine (PC) and 
phosphatidylethanolamine (PE) [13] indicating that lipids not directly bound to the protein are 
able to modulate protein-membrane interactions. Several experiments with cells suggested 
that the annexin family of proteins is responsible for Ca2+-dependent lipid segregation in 
muscle cells [14] and that AnxA2 is involved in microdomain regulation of exocytic sites 
[15]. Cholesterol plays also an important role in Annexins functions by modulating the 
binding to negatively charged phospholipids [16-18] (for a review see [19]), and recently it 
was shown that ceramide increases AnxA1 binding to biological and artificial membranes 
[20]. Finally, the binding and cellular distribution of AnxA6 in Ca2+-dependent and 
independent pools was shown to be modulated by cholesterol [21]. 
Several experiments demonstrated that cholesterol regulates the Ca2+-dependent and 
independent binding of AnxA2 to membranes in vitro [22] and in vivo [17, 23]. Moreover, 
this Ca2+-independent binding to membranes seemed to be induced by acidic pH as 
demonstrated in vitro [24, 25] and in vivo [26]. The role of PS in AnxA2 membrane binding 
is well known, but the role of PI2P in actin cytoskeleton membrane-related processes [27-29], 
in macropinocytosis [30] and exocytosis [31] has also been reported leading to the possibility 
that AnxA2 plays different cellular roles in membranes depending on their enrichment in PS 
or PI2P. 
In spite of the fact that many studies on lipid-AnxA2 interaction have been performed, a 
simple explanation of the annexin A2 effects on the membranes including different 
parameters such as calcium concentration, pH, lipid composition and the physicochemical 
properties of the membrane is lacking. In this study we performed comparative experiments 
with large unilamellar vesicles (LUV) of different composition focusing on the relative 
importance of PS, PI2P and cholesterol on AnxA2-membrane interactions. The results show 
that AnxA2 interaction with membranes and its effects depend on lipid organization. The 
Ca2+-sensitivity of AnxA2 is higher for PS-rich than for PI2P-rich membranes but it exerts a 
stronger reduction of membrane fluidity in PI2P-rich membranes. The membrane fluidity 
changes were also observed in cellular detergent-resistant membranes. 
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2. Material and Methods 
2.1. Reagents. Egg yolk L-α-phosphatidylcholine (PC), egg yolk L--
phosphatidylethanolamine (PE), brain L-α-glycerophosphatidyl-L-serine (PS) and cholesterol 
were purchased from Sigma-Aldrich. Brain L--phosphatidylinositol-4,5-bisphosphate (PI2P) 
was from Avanti polar lipids. Laurdan was from Molecular Probes. Di-4-ANNEPDHQ was 
obtained from Dr Leslie M. Loew (Connecticut, USA). Recombinant human AnxA2 and 
human S100A10 were purified as previously described [32]. The tetrameric complex 
(AnxA2T; (AnxA2-S100A10)2) was obtained by mixing equimolar quantities of AnxA2 and 
S100A10. The rabbit polyclonal anti-AnxA2 was produced in our laboratory. The rabbit 
polyclonal anti-Caveolin1 was from Santa Cruz Biotechnology. The anti-S100A10 and the 
anti-E-cadherin were from Transduction Laboratories. The goat anti-rabbit IgG-peroxidase 
and the secondary fluorescent (FITC, CY3 and CY5) conjugated anti-rabbit or anti-mouse 
antibodies were from Jackson ImmunoResearch. 
2.2. Large Unilamellar Vesicles. Multilamellar vesicles (MLVs) were obtained by dissolving 
the appropriate amounts of lipids (see table 1) in a mixture of chloroform and methanol, 2/1 
(v/v), followed by solvent evaporation under nitrogen. For fluorescence experiments, laurdan 
was added at 0.1% weight. Lipid films were hydrated with buffer A (40 mM Hepes pH 7, 30 
mM KCl, 1 mM EGTA) and vortexed extensively. Large unilamellar vesicles (LUV) were 
prepared by extrusion of MLVs through a polycarbonate filter (pore diameter 100 nm) as 
previously described [33]. 
2.3. Membrane bridging. LUVs aggregation by annexin A2-mediated membrane bridging was 
monitored by turbidimetry at 340 nm with a Cary spectrophotometer (Varian) as described 
[34]. The temperature was regulated with a Peltier device and controlled by a thermocouple. 
Free-Ca2+ concentration was controlled in buffer A as described [35]. The Ca2+ concentrations 
are expressed as pCa = -Log[Ca2+]. 5 μg of monomeric or tetrameric AnxA2 were added to a 
final 250 μl buffer containing 5 μg of LUVs (20 μg ml-1 for both protein and phospholipids). 
In these conditions, the lipid/protein molar ratio for interaction is 25. Considering that an 
annexin protein can cover between 26 to 31 nm2 and a phospholipid a surface of 0.6 nm2 [6, 
36, 37], there is enough protein to cover the entire surface of the vesicles. Moreover, in our 
pCa 3.3 and pH 4.5 experimental conditions there is 100% protein binding and vesicle 
aggregation [16, 22, 24, 32, 34]. In conclusion, the experiments are near saturation of bound 
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protein and therefore comparable. After protein addition the absorbance was followed for 7 
minutes. At this time membrane aggregation is very close to the plateau. Graphics and curves 
fitting were performed with Graphpad Prism software. 
2.4. Cell culture and immunofluorescence. Madin Darby Canine kidney (MDCK) cells were 
grown in Dulbecco’s modified Eagle’s medium (DMEM; Life Technologies, France) 
supplemented with 10% heat-inactivated fetal bovine serum (Life Technologies), penicillin 
(0.1 i.u./ml) and streptomycin (100 mg/ml). Cells were grown at 37°C in a 5% CO2/air 
atmosphere. To obtain differentiated epithelial MDCK cells, the cultures were recovered 2 
days after confluence. To obtain undifferentiated cells we used the Ca2+ switch strategy [38]. 
Briefly confluent MDCK cultures were incubated in a Ca2+-free medium for two days. This 
medium was prepared with Ca2+-free DMEM and serum dialyzed against PBS. For 
immunofluorescence the cells were cultured on glass cover-slips in 24 well plates. The cells 
were washed twice with PBS, and fixed with 3.7% paraformaldehyde in PBS for 15 minutes 
at room temperature. Then they were washed three times with PBS, NH4Cl 50 mM and post-
fixed and permeabilized with cold methanol (-20°C) for 1 minute and washed three times as 
before. Fixed cells were saturated with PBS, NH4Cl 50 mM, BSA 1% for 20 minutes at room 
temperature. The first antibody was added at the right dilution during 1.5 hours at room 
temperature followed by three washes in saturation solution. The secondary antibody was 
incubated and washed as the primary antibody. Finally, the cover-slips were washed in water, 
dried and mounted in Mowiol. All the fluorescence confocal images were acquired with a 
TCS SP2 laser-scanning spectral system (Leica, Wetzlar, Germany) attached to a Leica DMR 
inverted microscope (Platform Imagerie cellulaire et tissulaire, IFR65) at the specific 
excitation wavelengths and appropriate emission channels for each fluorophore. 
2.5. Detergent-resistant membranes from non differentiated and differentiated epithelial cells. 
The Triton X-100 detergent-resistant membranes (DRM) preparation was performed at 4°C. 
Cell cultures (from 75 mm flasks) were washed with PBS and lysed in buffer A containing 
Triton X-100 1% (w/v) and a protease inhibitor cocktail. The cell suspension was passed 10 
times through G23 and G26 needles. The cell extract was diluted with 80% sucrose solution 
in buffer A to obtain a final 40% sucrose suspension (4 ml) that was loaded in a SW41 
Beckman tube. 4 ml of 35% sucrose solution and 3.5 ml of 5% sucrose solution were 
sequentially added to the tube to obtain the discontinuous gradient. The tubes were 
centrifuged at 38 000 rpm for 18 hours at 4°C. After centrifugation, twelve 1 ml fractions 
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were recovered. Caveolin1 and AnxA2 contents were analyzed by Western blot on PVDF 
membranes by standard procedures using the ECL method (Amersham). 
2.6. Fluorescence recording. Fluorescence measurements were performed with a Cary 
fluorimeter (Varian) as previously described [39]. The protein and LUV concentration and the 
temperature regulation were as described in section 2.3. The excitation and emission band-
pass were set at 5 nm. For laurdan fluorescence, the emission spectra were recorded from 400 
to 650 nm using 365 nm excitation. Sequential spectra were recorded as follows: first, free 
LUVs in buffer A, then the LUVs in the presence of calcium (0.5 mM), and finally 10 
minutes after AnxA2 addition. For experiments at pH 4.5, the free-Ca2+ buffer B (40 mM 
acetate pH 4.5, 30 mM KCl, 1mM EGTA) was used. The excitation generalized polarization 
(GP) for laurdan was calculated as GP = (I440-I490)/(I440+I490), where I440 and I490 are the 
fluorescence intensities at the maximum emission wavelength in the ordered (440 nm) and 
disordered (490 nm) phases [40]. For DRMs, the probe di-4-ANNEPDHQ was used at 1 μM. 
This probe such as laurdan, is able to monitor membrane fluidity [41]. Ca2+ was added to 200 
μl of DRMs for a final 500 μM concentration. Then, 10 μg of AnxA2 were added and 
incubated for 15 minutes. Finally, to measure reversibility, EGTA was added (2 mM) and 
incubated for 30 min. before spectrum recording. The sequential emission spectra were 
recorded from 500 to 750 nm using 485 nm excitation and the wavelengths used for GP 
calculation were 570 and 630 nm for the ordered and disordered phases respectively. The 
statistical significance of the GP differences in figure 3 was assessed by ANOVA with 
GraphPad Prism. * P<0.05, ** P<0.01, *** P<0.001. 
 
3. Results 
3.1. Ca2+-dependency for membrane bridging by AnxA2 depends on lipid composition. In 
order to study the role of lipid composition on the Ca2+-dependency of AnxA2 for membrane 
bridging, we compared large unilamellar vesicles (LUV) containing phosphatidylserine (PS) 
as the AnxA2 ligand phospholipid and different quantities of cholesterol, phosphatidylcholine 
and phosphatidylethanolamine (PE) (Table 1). Briefly, PS-LUV1 are rich in PS, PS-LUV2 are 
rich in PS and cholesterol, PS-LUV3 contain PS, PE and cholesterol in similar quantities, PS-
LUV4 are rich in PE mimicking the inner leaflet of the plasma membrane without cholesterol 
and PS-LUV5 mimic the inner leaflet with cholesterol. Figure 1 shows that the Ca2+-
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dependency for membrane bridging by AnxA2 in its monomeric and tetrameric (complexed to 
the S100A10 dimer) forms at 23 and 37°C depends on the phospholipid composition. 
For the monomeric AnxA2, the higher Ca2_sensitivity was observed for the PS-LUV3 at 23 
and 37°C (see table 2). The half maximal aggregation was observed at pCa close to 5.8 (1.6 
μM free-Ca2+). PS-LUV1 presented the lower Ca2+-sensitivity with a pCa close to 4.4 (40 μM 
free-Ca2+) at both temperatures. For the other PS-LUVs, the values were placed in between 
these calcium concentrations range. The Ca2+-sensitivity did not correlate with the quantity of 
any phospholipid in the membranes. PS-LUV3 contains less PS than PS-LUV1 but more than 
PS-LUV4 or 5 (see table 1). Inversely, PS-LUV3 contains more PE than PS-LUV1 and 2 but 
less than PS-LUV4 or 5. At 37°C, the cholesterol content does not explain the difference in 
calcium sensitivity because PS-LUV1 and 4 with no cholesterol showed a pCa for half 
maximal aggregation very different at 37°C (4 and 5.4 respectively), and PS-LUV2 and 3 
with the same cholesterol content showed also a quite different pCa for half maximal 
aggregation (5 and 5.7 respectively). However, at 23°C, the Ca2+-sensitivity seemed to 
correlate with the cholesterol content showing lower Ca2+ concentration to bridge the PS-
LUVs with cholesterol (tables 1 and 2). 
For the tetrameric AnxA2, the Ca2+-sensitivity for membrane bridging at both temperatures 
was in the order: PS-LUV3>PS-LUV2>PS-LUV1>PS-LUV4>PS-LUV5 (Figure 1 and table 
3). As for the monomer, the Ca2+-sensitivity does not correlate with any particular lipid. PS-
LUV3, 4 and 5 contain PE, PS-LUV3, 2 and 5 contain cholesterol and the strongest quantity 
of the ligand phospholipid (PS) is in PS-LUV1 and 2. Overall, these results show that for both 
forms of the protein, there was no simple correlation of membrane bridging efficiency (Ca2+ 
concentration for half maximal effect) with the phospholipid composition. 
Considering that the most important differences in Ca2+-dependency for membrane bridging 
were observed with the monomeric AnxA2, in the next experiments we compared only the 
monomeric AnxA2 bridging capacity on LUVs containing phosphatidylinositol-4,5-
bisphosphate (PI2P-LUVs), the second phospholipid described to play an important role in 
AnxA2 binding to cell membranes. Figure 2 shows the Ca2+-dependency for aggregation of 
PI2P-LUVs at 23 and 37°C. The analysis of the Ca2+-sensitivity for aggregation revealed that, 
contrary to the PS-LUVs, the PI2P-LUVs 2 and 3 with high cholesterol content need more 
calcium to aggregate the membranes. The stronger Ca2+-sensitivity was observed for the 
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PI2P-LUVs with higher PE content and paradoxically with the lower PI2P content (table 2 
and figure 2) suggesting that PE facilitates AnxA2 binding to PI2P. 
The comparison of the AnxA2 Ca2+-dependency for membrane bridging of PS versus PI2P-
LUVs revealed different behavior for each phospholipid. The pCa for half maximal 
aggregation for PS-LUV5 and PI2P-LUV5 at both temperatures were about 5.2 and 5.4 
respectively. This difference can be considered as not significant. However, the pCa for PS-
LUV3 was about 5.8, a value completely different than that for PI2P-LUV3 (4.1 at both 
temperatures). The pCa values for LUV2 at 23°C showed also higher Ca2+-sensitivity for PS 
than for PI2P containing LUVs (5.2 and 4.5 respectively). 
These results show that the Ca2+-sensitivity for AnxA2-mediated membrane bridging does not 
follow a simple rule based in the ligand phospholipid quantity, and suggest strongly that the 
determinant factor of Ca2+-sensitivity for AnxA2-mediated membrane bridging is the 
organization of lipids in different membrane domains. 
3.2. Annexin A2 modulates membrane fluidity. The binding of AnxA2 to specific 
phospholipids would be expected to induce changes in membrane organization and properties. 
Therefore, we investigated whether AnxA2 modified membrane fluidity by using the 
fluorescent probe laurdan. This probe shows a spectrum centered at 440 nm in membranes in 
the gel phase (rigid) and centered at 490 nm in liquid disordered (fluid) phase. A spectral shift 
towards the blue indicates a decrease in membrane fluidity, a shift towards the red an increase 
in membrane fluidity. The state of a membrane can be quantitatively characterized by the 
ratiometric function GP (generalized polarization) (see methods). Therefore protein-induced 
membrane changes can be estimated by the ΔGP (GPfinal - GPinitial). A positive ΔGP indicates 
a decrease in fluidity and a negative ΔGP an increase in fluidity. 
The ΔGP (GPAnxA2-Ca2+-LUVs minus GPCa2+-LUVs) was measured for the five different PS-LUVs. 
As a control we used LUVs with a small quantity of ligand phospholipid (2.5 % of PI2P). 
With these LUVs in the absence of presence of cholesterol, no membrane aggregation was 
observed even at 1 mM free Ca2+, and laurdan spectra were not modified in the presence of 
the protein and Ca2+. Several spectra showing the AnxA2 effects in different conditions are 
illustrated in the supplementary figure S1 (additional file), and figure 3 shows the measured 
AnxA2-induced ΔGP. We used a calcium concentration of 500 μM because in these 
conditions all membrane binding sites will be occupied by the protein. Therefore, we were 
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sure that the differences observed were not due to differences in calcium dependent protein 
binding efficiency (this is the same for H+ concentration in the case of pH4.5 experiments). 
For the PS-LUVs in the presence of calcium (pCa 3.3), we observed a small decrease in 
membrane fluidity after AnxA2 addition at two temperatures (figure 3a). The PS-LUV4 
(plasma membrane mimicking without cholesterol) showed the stronger decrease in fluidity 
with a ΔGP value of about 0.03. The controls showed small ΔGP changes (from -0.004 to 
0.003). Because AnxA2 presents also a Ca2+-independent H+-dependent phospholipid binding, 
we performed the same experiments at pH 4.5. Figure 3b shows variable small decrease in 
fluidity after AnxA2 addition. However, with the PS-LUV1 (rich in PS without cholesterol), 
the effect was stronger at both temperatures (ΔGP values about 0.04). AnxA2 induced less 
effect in PS-LUVs containing cholesterol compared to the cholesterol-free membranes. In a 
second series of experiments, we studied the AnxA2 effect on PI2P-LUVs in the presence of 
calcium (pCa 3.3) and at pH 4.5. The results in figure 3c show that AnxA2 induced a decrease 
in fluidity of all PI2P-LUVs tested. At 23°C the tendencies of four PI2P-LUVs were similar 
to those observed with the PS-LUVs but they showed higher ΔGP values. At 37°C, with the 
exception of PI2P-LUV5, the effect was stronger for PI2P-LUVs compared to PS-LUVs with 
ΔGP values ranging from 0.04 to 0.07 indicating that the protein reduces the fluidity of PI2P-
membranes more than in PS-membranes. At pH 4.5 and 37°C, AnxA2 also induced high 
decrease in fluidity on PI2P-LUV4 compared to PS-LUVs (Fig. 3d). Overall, these results 
show that AnxA2-mediated reduction in fluidity is stronger in PI2P-LUVs than in PS-LUVs 
especially in the presence of calcium. 
To test whether AnxA2 was able to modify the fluidity of biological membranes we prepared 
Triton X-100 resistant membranes (DRMs) from undifferentiated and differentiated (epithelial 
polarized) MDCK cells. Figure 4a shows that in epithelial polarized cells, AnxA2 is localized 
on the lateral membranes where cell contacts are established and on the apical membrane as 
previously described [42, 43]. In undifferentiated cells AnxA2 is mainly cytosolic but a 
fraction remains associated with the plasma membrane (Figure 4b). The DRMs were 
separated by flotation in twelve fractions that were characterized. AnxA2 and caveolin1 were 
found in fractions 4 and 5 of differentiated cells (Fig. 4c). Therefore we used these fractions 
for the next experiments. 
The fluorescent probe used to monitor the fluidity changes of DRMs was di-4-ANEPPDHQ. 
Like laurdan, this probe is sensitive to the membrane fluidity and the cholesterol contents. It is 
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water soluble and fluoresces only when incorporated into the lipid bilayer. AnxA2 alone did 
not induce fluorescence indicating that the protein does not associate to the probe 
(supplementary Fig. S2 of additional file).  Figure 4d shows the di-4-ANEPPDHQ spectra of 
DRM fraction 5 from differentiated (D5) and undifferentiated (I5) MDCK cells indicating that 
DRMs from differentiated cells are less fluid (blue shifted) than those from undifferentiated 
cells (red shifted). This difference, also observed for fractions 4, is due to the fact that the 
plasma membrane of differentiated cells and especially the apical membrane is rich in 
cholesterol and sphingomyelin. The GPs were measured before and after AnxA2 addition to 
DRMs in the presence of 500 μM free calcium and the ΔGP was calculated. Figure 5a shows 
that Ca2+ does not change significantly the spectra of the DRMs. The ΔGP values in Figure 
5b, demonstrate that AnxA2 induces a decrease in fluidity of the DRMs at 23 and 37°C. The 
effect was smaller for the DRMs from differentiated MDCK cells (ΔGP values between 0.02-
0.03) than for DRMs from undifferentiated cells with ΔGP values about 0.04 at 37°C and 
0.06-0.07 at 23°C. The effect was reversible as shown by the addition of EGTA which 
induces AnxA2 membrane dissociation (Fig. 5a). These experiments demonstrate that AnxA2 
is able to reduce the fluidity of membranes from biological origin the effect being stronger at 
low cholesterol content. 
 
4. Discussion 
The annexins specificity for different phospholipids has been studied in several conditions [6, 
7, 10]. Phospholipid preferences are not exclusive of annexins and are shared by other 
domains such as the plekstrin domain of evt-2 protein which prefers PS to PIs [44]. Herein, 
we show that the Ca2+-sensitivity for annexin A2 mediated membrane bridging does not 
correlate with the concentration of the anionic phospholipid involved in binding (PS or PI2P). 
However, some interesting tendencies were observed (supplementary figure S3). First, the 
presence of cholesterol results in a decrease in the calcium concentration necessary for 
membrane bridging of PS-LUVs. This fact is consistent with the previously published 
enhancement of AnxA2 membrane binding by cholesterol [16, 17, 22, 23]. However, for the 
PI2P-containing membranes the Ca2+-sensitivity enhancement by cholesterol was not clear. 
The second tendency was that the PI2P-LUVs rich in PE showed lower calcium requirements. 
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These data demonstrate that the annexin A2-mediated membrane bridging depends more on 
the organization of phospholipids (membrane domains) than on the global concentration of a 
specific ligand and that each ligand phospholipid has specific environmental conditions for 
efficient Ca2+-dependent binding of AnxA2. For example, with PS-LUV1, 2 and 3 AnxA2 
required lower calcium concentrations compared to PI2P-LUVs, but AnxA2 required similar 
calcium concentration for PS- and PI2P-LUV5.  However, in most cases, we observed higher 
calcium requirement for PI2P than for PS containing LUVs. The strong negative charge of 
PI2P would require higher Ca2+ concentration for charge titration (decrease in charge 
mediated repulsion) to allow AnxA2 bridging. These data suggest that the spontaneous 
distribution of membrane lipids create domains rich or poor in ligand phospholipids allowing 
the protein to bind at low or high calcium concentrations. 
Considering the capacity of AnxA2 to change the membrane fluidity, we observed that the 
protein was able to reduce membrane fluidity. The strength of this effect was also dependent 
on the lipid composition. In the presence of calcium, PS-LUVs showed weak decrease in 
membrane fluidity after AnxA2 binding. PS-LUV4 which contains no cholesterol and low PS 
content showed moderate effect (supplementary figure S3). In the absence of calcium and at 
mild acidic pH, the decrease in fluidity of the PS-LUVs without cholesterol was stronger than 
in the presence of calcium. Interestingly, the capacity of AnxA2 to reduce the fluidity of 
PI2P-LUVs was stronger compared to the PS-LUVs. This effect was also enhanced in 
cholesterol-free PI2P-LUVs. This tendency was also observed at acidic pH. However, 
contrary to the PS-LUVs, the effect was stronger with calcium than at acidic pH 
demonstrating again phospholipid-dependent behavior.  
To test the AnxA2 effects on membranes from biological origin, we prepared TX-100 
resistant membrane fractions from differentiated and undifferentiated cells.  These fractions 
can be considered as DRMs from different cell types. The differentiated MDCK cells present 
an apical membrane rich in cholesterol and sphingolipids which are characteristic of the raft-
DRM domains and present higher order compared to the basolateral membrane (see the 
MDCK lipidomic characterization in [45])The undifferentiated cells do not present this apical 
membrane. Therefore it was expected that the DRMs from these two cell types were different. 
Those from differentiated cells are rich in cholesterol and thus more rigid. The DRMs from 
undifferentiated cells have less cholesterol and are more fluid. The fact that DRMs can be of 
quite different composition was previously discussed in [46]. In spite of the fact that the TX-
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100 treatment can induce the redistribution of cholesterol creating membrane "domains" [47], 
the idea in this work was to test the effect of Anx2 in two DRMs of different composition 
with different rigidity and cholesterol content and containing natural lipid species and 
membrane proteins. As shown by the ANNEPDHQ spectra, the differentiated DRMs rich in 
apical membrane show higher rigidity due in part to their high cholesterol content [41]. The 
results we observed with DRMs are consistent with the results from LUVs indicating that 
Anx2 induction of rigidity is stronger in fluid membranes than in rigid membranes. The 
presented data is also consistent with reports showing that some annexins are able to 
redistribute phospholipids [9, 11, 12] and change the membrane fluidity [48] depending on the 
phospholipid composition [10, 13]. 
The explanation for the AnxA2-mediated membrane fluidity reduction must be based on the 
capacity of annexins to bind specific anionic phospholipids. After phospholipid binding, the 
different affinities between all the lipids may determine their redistribution. This 
redistribution will depend on two facts: 1) the creation of new spacing between the anionic 
protein-bound phospholipid and 2) the change of the head group charge interactions. In other 
words, the binding of four anionic phospholipids to the four AnxA2 repeats, would change 
first the original distances between them restraining their movement, and second, the charges 
on the head groups would be differently oriented with the consequent change of repulsion-
attraction forces between the bound phospholipids and the unbound lipids. This spacing and 
charge changes will allow lipid redistribution in different domains (Fig 6a). Considering that 
the overall lipid volume, the head group size and the net charge of PI2P are higher than PS, it 
is expected that AnxA2 bound to PS or PI2P will induce different effects on the membrane 
lipid redistribution with the consequent differences in the physicochemical properties of the 
membranes.  
How do these data help to understand the role of lipids on AnxA2 functions? Based on our 
results we suggest that in the cell, the Ca2+ or H+ requirements for membrane binding and the 
functions and effects of AnxA2 will be different depending on the target membrane. In the 
absence of Ca2+ at low H+ concentration, AnxA2 would bind preferentially to PS-cholesterol-
rich membranes and/or PI2P-cholesterol-poor membranes with a strong effect on the PI2P-
membranes. This situation would be implicated for the endosomal functions of annexin A2 in 
which the protein seems to bind the membrane in a Ca2+-independent manner [17, 23], but 
also to the reported H+ dependent binding to the plasma membrane [26]. In the presence of 
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calcium, AnxA2 will be able to bind to the PIP2-cholesterol-rich membranes and/or to the PS-
cholesterol-poor membranes with a strong decrease in fluidity of membranes poor in 
cholesterol and rich in PE. This situation would represent the annexin A2 role in Ca2+-
mediated processes such as the stimulated exocytosis in endothelial and chromaffin cells [15, 
49, 50] in which AnxA2 was found to localize in PI2P-enriched exocytic domains [31]. 
Therefore, AnxA2 will induce specific effects for the reported functions such as Ca2+-
mediated secretion, endosomal regulation and plasma membrane domains organization. 
 
5. Conclusions 
The data schematically represented in figure 6b (see also supplementary figure S3), show that; 
1) the PS membranes require less calcium than the PI2P membranes for AnxA2 membrane 
bridging. 2) Cholesterol reduces the calcium requirements for AnxA2 on PS membranes. 3) 
AnxA2 decreases the fluidity of PI2P membranes more than the PS membranes. 4) AnxA2 
diminishes the fluidity of the PS membranes more in the presence of H+ than in the presence 
of Ca2+, but the effect on PI2P membranes is stronger in the presence of Ca2+ than at acidic 
pH, and 5). Cholesterol reduces AnxA2 capacity to reduce membrane fluidity. These data 
shed light on the molecular mechanisms necessary to understand the specific effects of 
Annexin A2 in membranes rich in PI2P, PS or cholesterol and also in membrane domains 
regulation [14, 15, 27-29]. However, for the fine understanding of the AnxA2 functions on 
membrane regulation, the future lipidomic analysis of cellular AnxA2 target membranes is the 
next step to take.  
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Figures 
 
 
Figure 1. PS-LUVs bridging by Annexin A2 as a function of calcium. Vesicle aggregation in percent 
of maximal OD for monomeric AnxA2 at 23°C (a) and 37°C (b), and for tetrameric AnxA2 at 23°C 
(c) and 37°C (d). LUVs composition is shown in table 1. PS-LUV1 (■ dash double dotted line), PS-
LUV2 (● dash dotted line), PS-LUV3 (▲ dashed line), PS-LUV4 (□ dotted line) and PS-LUV5 (○ 
continuous line). The calcium concentration for half maximal aggregation (EC50 as pCa) and the 
number of experiments performed are shown in tables 2 and 3. 
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Figure 2. PI2P-LUVs bridging by Annexin A2 as a function of calcium. Vesicle aggregation in percent 
of maximal OD for AnxA2 at 23°C (a) and 37°C (b). The LUVs composition is in table 1. PI2P-LUV1 
(■ dash double dotted line), PI2P-LUV2 (● dash dotted line), PI2P-LUV3 (▲ dashed line), PI2P-
LUV4 (□ dotted line) and PI2P-LUV5 (○ continuous line). The calcium concentration for half 
maximal aggregation (EC50) and the number of experiments performed are in table 2.  
 
Figure 3. Changes in membrane fluidity induced by AnxA2. Changes in membrane fluidity expressed 
as ΔGP (GPAnxA2-LUVs - GPfree-LUVs). PS-LUVs at 23 and 37°C in the presence of 500 μM calcium (a). 
PS-LUVs at 23 and 37°C at pH 4.5 (b). PI2P-LUVs at 23 and 37°C in the presence of 500 μM calcium 
(c). PI2P-LUVs at 23 and 37°C at pH 4.5 (d). Bars are the mean ± Std. error from 2 to 8 experiments. 
* P<0.05, ** P<0.01, *** P<0.001. 
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Figure 4. Cellular distribution of Annexin A2 and characterization of the DRM fractions of 
differentiated and undifferentiated MDCK cells. AnxA2 labeling in confocal slices of differentiated 
epithelial (a) and undifferentiated MDCK cells (b). AnxA2 (green), S100A10 (red) and E-cadherin 
(blue). Confocal images in the XY plane on top and in Z plane (AnxA2 (green) and E-cadherin (red)) 
at bottom. Bars; 10 μm. (c); Western blots of AnxA2 and Caveolin1 in discontinuous sucrose gradients 
from differentiated (D) and undifferentiated (I) cells. DRMs are found in fractions 4 and 5. (d); Di-4-
ANEPPDHQ spectra of fractions 5 from undifferentiated (continuous line), and differentiated cells 
(dotted line). DRMs from differentiated cells are less fluid (blue shifted) than those from 
undifferentiated cells. 
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Figure 5. Annexin A2 reduces the fluidity of detergent resistant membranes (DRMs). (a); 
representative di-4-ANEPPDHQ spectra of DRM fraction 4 from undifferentiated cells (dotted line), 
after sequential addition of 500 μM free-Ca2+ (dashed line), AnxA2 (continuous line, arrow), and 
addition of EGTA 1 mM to test the reversibility of the AnxA2 effect (dash-dotted line). Spectra were 
obtained at 23°C. (b); ΔGP after AnxA2 addition on DRM fractions 4 and 5 from epithelial 
differentiated (D4, D5) and undifferentiated (I4, I5) MDCK cells at 23 and 37°C. Mean of two 
experiments in triplicate. Notice the stronger effect induced by AnxA2 on DRMs from 
undifferentiated cells (I). 
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Figure 6. Schematic representation of AnxA2 effects on membranes. In left part of (a) the membrane 
is composed of different lipids (geometric figures) distributed in different domains. After AnxA2 
(oval) binding, the ligand phospholipid associates strongly to the protein (gray circles). This 
interaction (right of a) provokes the redistribution of lipids with the consequent creation of new 
domains with different properties. The zone of the membrane that is not in contact with the protein 
might be modified by the protein-induced redistribution of lipids (box). (b) Illustrates the preferences 
of AnxA2 for the different phospholipids in the presence or the absence of calcium and the associated 
effect on fluidity. The Ca2+-independent action is schematized in gray, the Ca2+-dependent process in 
black. Phospholipids are abbreviated as in the text and cholesterol by CH. Membrane fluidity is 
schematized at the bottom. Strong reduction in membrane fluidity is coded by the straight bars, 
fluidity by rippled bars and moderate AnxA2 effect by straight-rippled bars. See details in the text. 
Tables 
Table 1. Lipid composition of large unilamellar vesicles (LUV). 
 Lipid (weight %) 
LUV PCa PS or PI2Pb PE Cholesterol 
LUV1 75 25 0 0 
LUV2 50 25 0 25 
LUV3 20 20 35 25 
LUV4 25 15 60 0 
LUV5 17 12 52 19 
a; Phosphatidylcholine 
b; Depending on the experiment, the anionic phospholipid ligand for AnxA2 was phosphatidylserine 
(PS) or phosphatidylinositol-4,5-bisphosphate (PI2P). 
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Table 2. Calcium concentration for half maximal membrane bridging (EC50) by monomeric 
AnxA2 (pCa)a. 
 PS containing LUV 
PS-LUV1 PS-LUV2 PS-LUV3 PS-LUV4 PS-LUV5 
AnxA2 23°C 4.37±0.09 (8) 5.28±0.05 (6) 5.81±0.03 (8) 4.78±0.14 (9) 5.26±0.28 (9) 
AnxA2 37°C 4.04±0.04 (5) 5.04±0.07 (6) 5.70±0.04 (5) 5.38±0.08 (7) 5.19±0.06 (6) 
 PI2P containing LUV 
 PI2P-LUV1 PI2P-LUV2 PI2P-LUV3 PI2P-LUV4 PI2P-LUV5 
AnxA2 23°C 3.72±0.53 (5) 4.57 (2) 4.14±0.11 (4) 5.07±1.12 (5) 5.33±0.07 (4) 
AnxA2 37°C nd nd 4.15 (2) 5.30±0.07 (3) 5.48±0.03 (3) 
a: The values are expressed in pCa ± Std. error (N). 
nd: not determined. 
 
Table 3. Calcium concentration for half maximal membrane bridging (EC50) by tetrameric 
AnxA2 (pCa)a. 
 PS containing LUV 
PS-LUV1 PS-LUV2 PS-LUV3 PS-LUV4 PS-LUV5 
AnxA2T 
23°C 
6.20±0.04 (6) 6.50±0.07 (4) 6.77±0.04 (4) 6.19±0.03 (4) 6.01±0.06 (5) 
AnxA2T 
37°C 
6.28±0.03 (4) 6.59±0.03 (4) 6.72±0.04 (4) 6.14±0.03 (5) 6.05±0.03 (6) 
a: The values are expressed in pCa ± Std. error (N). 
nd: not determined. 
 
